Kathryn L. Murray, M.S., CGC

Experience

• 

  Fetal Diagnostic Center

  Jan 1990 - Jan 1998

  Director of Genetic Services & Senior Genetic Counselor

  Developed this practice for the tertiary care hospital, from the ground up, to support its NICU with genetic and maternal fetal medicine services. Partnered with the founding physician and developed an entire portfolio of genetic services and supplementary community education for the surrounding community of providers and patients in the entire state of Oregon. Additionally, established and led out processes for office and operations management, forecasted budgets, & led hiring decisions.🔹 Managed a $500k budget for operations that serviced 1.2M patients in 12 counties over 64k sq. mi.🔹 Led up and across a founding team of 5 that grew to more than 20 including physicians, specialists, and office staff🔹 Justified the departments overall financial impact within the overall tertiary hospital’s operations and revenues to secure stable funding for continued services and future growth🔹 Established this department as the leader in genetics and maternal fetal medicine by championing services, providing education to providers and the community, developing strong partnerships with providers, and creating excitement around the industry;- Developed a strong reputation for patient centered services which resulted in exponentially more referrals, which enabled the improvement of genetic medicine for the community and outlying areas Show less

• 

  Center for Genetics and Maternal Fetal Medicine

  Dec 1998 - now

  Director of Genetic Services

  Began this practice as the founding genetic counselor (at the Fetal Diagnostic Center) and evolved it through this organization with continued oversight of the development, implementation, and coordination of Genetic Services, including prenatal diagnosis, inherited cancer syndromes, and adult neurological disease. Field all operational decisions for the office, servicing 19 internal physicians, several midwives, and 4 offices of specialized patient services while providing direct patient care and counseling patients through critical genetic decisions.Helmed the development of the genetic community and mindset to successfully bring in much recognition in genetics for the region by consulting with key community physicians, physician influencers, and KOL champions.Key Accomplishments:🔹 Intellectually resolved a medical quandary for a family who presented a fetus at risk for a life-threatening condition: hemolytic disease of the newborn;- Gathered, sorted, and reviewed the discrepancies between lab results from several laboratories (partnering with various stakeholders, including parents, doctors, laboratories) and determined the medically correct recommendation that prevented future harm to the fetus🔹 Leveraged expertise in prenatal cfDNA testing and cancer genetics and identified a patient with unique prenatal cfDNA results, a case that had potential for much broader implications in genetic/oncology medicine;- Partnered with Dr. Diana Bianchi on further research and patient identification and co-wrote a landmark paper that contributed to the greater knowledge of genetics and led to the formation of GRAIL;- Publication: Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies (JAMA. 2015;314(2):162-169) Show less

• 

  Legal Consultant for Keating & Hughes, P.C.

  Jan 2007 - Jan 2007

  Moran v. Siskiyo Community Health Center
• 

  Legal Consultant for Johnson, Clifton, Larson & Schaller, P.C.

  Jan 2011 - Jan 2011

  Legal Consultant

  Neonatal case in which thechild suffered brain damage

• 

  Community Cancer Risk Assessment Project in collaboration with Myriad

  Jan 2012 - Jan 2013

  Senior Researcher

  Designed, led out, and executed a pilot project for the community education of expert providers (surgeons, oncologists, and gastroenterologists) for genetic counseling leading to genetic testing that could identify individuals at high risk for cancer and provide multi-faceted education to initiate appropriate screening and sensitive follow-up that could reduce the morbidity and mortality from cancer;- Over 12 weeks, partnered with the 3 largest specialty providers, locally, and coordinated with several leads (15+ individuals) to provide education and develop educational materials for in-office use- Formed a community of 10 highly-interested providers and developed their confidence and skillsets, through education and 1:1 training, allowing for the treatment of more patients and the personalization of screening and management- Several of these providers have approved and implemented additional training and the entire group is preparing to move on to the next step of genetic medicine in cancer Show less